VBI Vaccines Inc.

NASDAQ:VBIV

0.0653 (USD) • At close August 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 8.6821.0820.6311.0612.2213.3550.8650.5480.9550000000000000.00100.0690.0660.070.072
Cost of Revenue 14.49711.27610.779.1687.9044.5095.1933.6713.75504.63710.8170000.0090.0130000000000
Gross Profit -5.815-10.194-10.139-8.107-5.683-1.154-4.328-3.123-2.80-4.637-10.817000-0.009-0.01300000.00100.0690.0660.070.072
Gross Profit Ratio -0.67-9.421-16.068-7.641-2.559-0.344-5.003-5.699-2.932000000000011111111
Reseach & Development Expenses 9.34315.50619.55814.85926.33238.46720.9189.9660.618000000000000000000
General & Administrative Expenses 42.14356.1238.33520.65114.09220.78712.03411.7616.6831.4182.4122.53317.5590.7320.3260.5930.4290.4540000.0710.0860.0690.1330.1410.145
Selling & Marketing Expenses -1.9900000000000.250.1180.1270-0.026-0.07-0.065000000000
SG&A 40.15356.1238.33520.65114.09220.78712.03411.7616.6831.4182.4122.78317.5590.7320.3260.5670.3590.3890.130.1320.0820.0710.0860.0690.1330.1410.145
Other Expenses 24.60020.65120.38420.78712.03411.7610.8623.8724.9670.012000000000000000
Operating Expenses 49.49671.62657.89335.5140.42459.25432.95221.7278.1635.297.382.79517.5590.7320.3260.5670.3590.3890.130.1320.0820.0710.0860.0690.1330.1410.145
Operating Income -55.311-81.82-68.032-43.617-52.399-60.408-37.28-24.85-8.836-5.148-7.119-13.767-17.559-0.732-0.258-0.576-0.368-0.35-0.135-0.137-0.089-0.563-0.19-0.069-0.133-0.282-0.217
Operating Income Ratio -6.371-75.619-107.816-41.109-23.593-18.005-43.098-45.347-9.2520000000000-1,728.163-179.316-1,107.882-300,076.89-1-2-4-3
Total Other Income Expenses Net -37.525-31.483-1.721-2.613-2.414-0.560.7360.189-2.8160.1440.261-0.155-1.3370.014-0.0140.006-0.0050.036-0.006-0.005-0.008-0.493-0.1050-0.066-0.211-0.072
Income Before Tax -92.836-113.303-69.753-46.23-54.813-63.6-39.426-24.985-14.884-4.594-6.653-13.155-18.896-0.717-0.331-0.558-0.365-0.314-0.135-0.137-0.097-0.07-0.2950-0.199-0.493-0.29
Income Before Tax Ratio -10.693-104.716-110.544-43.572-24.679-18.957-45.579-45.593-15.5850000000000-1,728.163-196.313-138.535-465,169.8290-3-7-4
Income Tax Expense 1.82227.6482.8971.0560.9920.56-0.431-1.78-0.129-0.84-0.987-0.3032.631-0.0280.015-0.024-0.159-0.082-0.0840.010.0170.986-0.0030.0690.0660.07-0.072
Net Income -92.836-140.951-72.65-47.286-55.805-63.6-38.995-23.205-14.755-4.594-6.653-13.155-18.853-0.717-0.331-0.558-0.205-0.343-0.051-0.137-0.09-0.563-0.188-0.069-0.199-0.352-0.217
Net Income Ratio -10.693-130.269-115.135-44.567-25.126-18.957-45.081-42.345-15.450000000000-1,728.163-182.019-1,107.882-295,773.891-1-3-5-3
EPS -5.96-16.37-8.55-6.5-14.02-29.06-26.49-23.17-35.05-21.27-32.73-66.64-287.5-15.27-8.75-15.36-6.53-15.87-2.82-9.1-8.18-45.14-15.23-8.26-23.86-33.81-26.09
EPS Diluted -5.96-16.37-8.55-6.5-14.02-29.06-26.49-23.17-35.05-21.27-32.73-66.64-287.5-15.27-8.75-15.36-6.53-15.87-2.82-9.1-8.18-45.14-14.25-8.26-23.86-33.81-26.09
EBITDA -53.321-81.82-68.032-43.617-46.107-59.244-36.55-24.244-9.8-5.404-7.605-13.438-16.216-0.744-0.311-0.582-0.365-0.425-0.121-0.126-0.0720.4230.019-0.069-0.1990.141-0.217
EBITDA Ratio -6.142-75.619-107.816-41.109-20.76-17.658-42.254-44.241-10.2620000000000-1,588.942-146.59831.99430,108.989-1-32-3